A nanoparticle vaccine that combines two proteins that induce immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that has caused the global pandemic, has the potential to be developed into broader and safe SARS-CoV-2 vaccines, according to researchers in the Institute for Biomedical Sciences at Georgia State University.
Click here for original story, Protein nanoparticle vaccine shows potential for broader, safe SARS-CoV-2 vaccines
Source: Phys.org